zoxy

Wow, I was unaware of this. Apparently the two Alberta schools had 342 graduates participating in CaRMS in 2013 and 2014. According to the AFMC, In rhe 2021 admission cycle, the UofA had 162 seats and UofC had 150 for a total of 312 across the two schools. That's a 9 percent decline in spots despite Alberta's population increasing by 10 percent between 2013 and 2021 alone. And Kenney and Shandro are still fighting doctors.

It will in all likelihood fail. York's been trying for a school since at least 08 and they didn't get one in much better fiscal times. Opening a brand new school with the requisite LMCC accreditation will require far more money than adding positions at already established schools. Especially since a Brampton campus would be smack dab between UofT and McMaster and wouldn't really add much in terms of geographical diversity and serving underprivileged populations. It would make much more sense to just expand UofT's Missassauga campus, which is next to Brampton, than to build a new school in that

It's only at a proposal stage. The reason it's proposed to be in Brampton is because Brampton kicked in 1 million for the proposal, the same amount that the Ontario government pitched in. Anyway, a new medical school, additional residency spots for its graduates, and the billings of the newly minted physicians would put a significant fiscal strain on the Ontario government. The ON government just ran a 39 billion dollar deficit in 2020-21. Health care spending is 38 percent of the provincial budget and growing with the aging population. The Ontario government and Ontario doctors have been

Toronto, McMaster, and Calgary haven't released their quotas yet. That's over 600 spots between the three of them.

I'm not sure since that's such a unique case. Also I'm uncertain how easy a transition into derm from a peds residency in the US would be. If you want more info, take a look at these Royal College requirements for specifics: https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjuncmp8NTzAhVeQTABHbz9DS8QFnoECAMQAQ&url=https%3A%2F%2Fwww.royalcollege.ca%2Frcsite%2Fdocuments%2Fibd%2Fdermatology-str-e.pdf&usg=AOvVaw1EjzCq2nD08L33pgCnFhbY https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=w

For all of the specialties that are one year shorter in the US in Canada, you need to do a year of residency in Canada or a year of fellowship to be able to sit the Royal College. If you look around you can find examples of people who did that and the Royal College documents also explains the process. I know an EM physician in Calgary who did med-school in Australia, her 4 years EM residency at Harvard, and then had to do a year of residency in Saskatoon in order to qualify for the Royal College in EM. The irony is that there are plenty of physicians who work in EM with an FM+1 backgroun

Specialties that are somewhat competitive in Canada and much less competitive in the US. Psychiatry, IM, EM, and Pediatrics are what immediately springs to my mind. I think Rads might have been one as well a few years ago, but it's getting less competitive in Canada due to AI fear mongering and fear of impending cuts to imaging payments. By looking at your profile name, it's looks like you want to match Derm. If that's the case, it's similarly competitive down in the US and I don't think barring insane USMLE scores and research, you'd have a great chance of matching Derm down there. In fa

For 2021 and 2022 this is indeed the case. Do you think CaRMS will revert to running earlier than NRMP for 2023 and beyond?

This is especially true now that the DO and MD residencies are merging and all the DO programs are getting ACGME accreditation. This means that DO residencies that would have been previously not accepted by the Royal College will now be acceptable for reciprocal certification. This makes DO an even better option than it used to be pre-merger.

I'm terrible at evaluating ECs. Each school evaluates ECs differently anyway and I'm not sure how Calgary does it. Anyway, mulling over it doesn't really matter at this point for this cycle. You either get an interview or you don't. Nothing that you do right now can impact that and that includes evaluating your ECs. However, that's not the case for next cycle. Work on improving your ECs, especially if there are holes, and retake the MCAT for next cycle with a particular emphasis on the CARS section. Your GPA is only 0.01 less than the average matriculant so it's not what's holding yo

This isn't the US where being a re-applicant is looked down upon. There is no benefit to withdrawing in Canada. UCalgary is very EC heavy anyway. A bad CARS or MCAT won't sink you if you have excellent ECs and are IP. You paid the application fee for them to evaluate your application, it's the least they could do for 150 bucks.

Their procedures and data are quite clear. https://medicine.usask.ca/documents/ugme/admission/saskatchewan-resident-applicant-information.pdf https://medicine.usask.ca/documents/ugme/admission/admissions-statistics-5-year-summary.pdf

I assume that receiving an interview offer would mean passing the CASPer cutoff and not having to worry thereafter. At least that's what reading the admissions manual leads me to believe.

It's not used for ranking yet. Ranking for interview is based on 40 percent MCAT z-score and 60 percent GPA z-score for IP applicants and purely MCAT score for OOP, as long as OOP meet the GPA cutoff. The CASPer is used as a cutoff for both groups and not for ranking purposes. The director of admissions previously said that they would it used it very conservatively for the 2020-21 cycle. For that cycle, they would only eliminate those with CASPer scores more than two standard deviations below the mean (2-3 percent in a normal distribution) or with red flags in their CASPer. It's unknown i

Any idea when COVID-19 will cease to be an issue? Because that would answer your question.